Abstract
Gram-negative bacteria harbouring the mcr-1 plasmid are resistant to the 'last-line' polymyxins and have been reported worldwide. Our objective was to define the impact of increasing the initial polymyxin B dose intensity against an mcr-1 -harbouring strain to delineate the impact of plasmid-mediated polymyxin resistance on the dynamics of bacterial killing and resistance. A hollow fibre infection model (HFIM) was used to simulate polymyxin B regimens against an mcr-1 -harbouring Escherichia coli (MIC 8 mg/L) over 10 days. Four escalating polymyxin B 'front-loading' regimens (3.33, 6.66, 13.3 or 26.6 mg/kg for one dose followed by 1.43 mg/kg every 12 h starting 12 h later) simulating human pharmacokinetics were utilized in the HFIM. A mechanism-based, mathematical model was developed using S-ADAPT to characterize bacterial killing. The 3.33 mg/kg 'front-loading' regimen resulted in regrowth mirroring the growth control. The 6.66, 13.3 and 26.6 mg/kg 'front-loading' regimens resulted in maximal bacterial reductions of 1.91, 3.79 and 6.14 log 10 cfu/mL, respectively. Irrespective of the early polymyxin B exposure (24 h AUC), population analysis profiles showed similar growth of polymyxin B-resistant subpopulations. The HFIM data ...Continue Reading
References
Mar 10, 2010·Antimicrobial Agents and Chemotherapy·Jürgen B BulittaBrian T Tsuji
Mar 4, 2011·The AAPS Journal·Jurgen Bernd BulittaCornelia Barbara Landersdorfer
May 24, 2013·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Ana M SandriAlexandre P Zavascki
Dec 18, 2013·Antimicrobial Agents and Chemotherapy·Gauri G RaoBrian T Tsuji
Feb 18, 2014·Journal of Pharmaceutical and Biomedical Analysis·Soon-Ee CheahRoger L Nation
Nov 26, 2015·The Lancet Infectious Diseases·Yi-Yun LiuJianzhong Shen
Dec 10, 2015·Infectious Diseases and Therapy·Phillip J BergenBrian T Tsuji
Jan 18, 2016·The Lancet Infectious Diseases·Linda FalgenhauerUNKNOWN RESET consortium
Jan 18, 2016·The Lancet Infectious Diseases·Laurent PoirelPatrice Nordmann
Mar 1, 2016·Scientific Reports·Mohd Hafidz Mahamad MaifiahJian Li
Mar 15, 2016·The Lancet Infectious Diseases·Michael R MulveyRoberto G Melano
Mar 16, 2016·Antimicrobial Agents and Chemotherapy·Kun-Jiao ZengGuo-Bao Tian
Apr 14, 2016·Antimicrobial Agents and Chemotherapy·Brian T TsujiJian Li
Apr 20, 2016·The Journal of Antimicrobial Chemotherapy·Michel DoumithNeil Woodford
May 4, 2016·South African Medical Journal = Suid-Afrikaanse Tydskrif Vir Geneeskunde·Jennifer CoetzeeAdrian John Brink
May 20, 2016·Scientific Reports·Soon-Ee CheahJian Li
May 28, 2016·Antimicrobial Agents and Chemotherapy·Patrick McGannKurt E Schaecher
Jul 13, 2016·Antimicrobial Agents and Chemotherapy·Mariana CastanheiraRobert K Flamm
Oct 22, 2016·Trends in Microbiology·Gerard D Wright
Jul 22, 2016·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·Peter J CollignonGun-Jo Woo
Aug 16, 2016·International Journal of Antimicrobial Agents·Sophie BaronAbiola Olumuyiwa Olaitan
Sep 1, 2016·MBio·José R MediavillaBarry N Kreiswirth
Sep 17, 2016·The Journal of Antimicrobial Chemotherapy·Justin R LenhardBrian T Tsuji
Citations
Jul 27, 2017·MBio·Zackery P BulmanBrian T Tsuji
Feb 3, 2019·Pharmacotherapy·Brian T TsujiKeith S Kaye
Dec 29, 2020·International Journal of Antimicrobial Agents·Hubert C ChuaBrian T Tsuji
May 11, 2020·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·N J OnufrakZ P Bulman
Feb 18, 2020·Clinical Microbiology and Infection : the Official Publication of the European Society of Clinical Microbiology and Infectious Diseases·N M SmithB T Tsuji
Jun 29, 2021·The Journal of Antimicrobial Chemotherapy·Zahra SadoukiFrank Kloprogge
Jun 8, 2021·Antimicrobial Agents and Chemotherapy·Michael MaynardArnold Louie
Aug 20, 2021·Infection and Drug Resistance·Chen HuangYonghong Xiao